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Putative Antibiotic Producer: A Pseudomonas genus with 
Antibiotic Properties
John Tworek and Dr. Lori Scott
INTRODUCTION
There is a serious crisis evolving in the world with catastrophic 
consequences if action is not taken. Many diseases caused by 
bacteria are becoming untreatable because of the amount of 
pathogens resistant to the effect of antibiotics. The Center for 
Disease Control and Prevention (CDC) reports that over 2.8 
million people acquire serious resistant infections, and over 
35,000 die as a result from these infections.1 The most prolific 
bacteria known to cause these deaths are Enterococcus faecium, 
Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter, or 
ESKAPE bacteria. They are nosocomial pathogens that exhibit 
multidrug resistance and virulence.2 The mechanisms involved in 
multidrug resistant pathogens are broadly grouped into three 
categories: drug inactivation commonly by an irreversible 
cleavage catalyzed by an enzyme, modification of the target site 
where the antibiotic may bind, and reduced accumulation of drug 
either due to reduced permeability or by increased efflux of the 
drug.3 There are multiple treatment strategies to combat this issue 
including antibiotics in combination. This uses multiple 
antibiotics simultaneously, which can be effective because it is 
more unlikely for bacteria to be resistant to multiple antibiotics.2
The Tiny Earth Project (TEPI) is a network of students and 
professors collaborating around the world to address, and fix the 
antibiotic crisis.4 My project will be working with the TEPI to 
educate the public about the antibiotic crisis, and obtaining a soil 
sample to isolate the bacteria in it to discover new antibiotics. 
Antibiotics are secondary metabolites, naturally found in soil, that 
inhibit the growth of other microorganisms. Efforts aimed at 
identifying new antibiotics were once the priority of research and 
development among pharmaceutical companies, but there is now 
a long list of microbes that are no longer susceptible to most 
therapeutic agents.5
Figure 1. Streak plates of Escherichia coli (left) and Bacillus 
subtilis (right). Both samples were grown overnight for 23 hours 
at 30°C. B. subtilis is a spore former which allows for greater 
mobility on the LB agar plates, and has significant growth 
compared to E. coli. More streaking will continue in the future, 
but due to the size and amount of growth on both plates both will 
be grown for 23 hours at 30°C.7
Along with the unknown bacteria from the collected soil sample, 
I will be working with the ESKAPE-related tester strain 
Escherichia coli, and Bacillus subtilis. E. coli grows in a straight
cylindrical rod, typically in pairs, and is Gram-negative. E. coli is 
naturally found in the lower part of the intestine. B. subtilis is rod-
shaped, growing in chains, and is Gram-positive. It is naturally 
found in the gastrointestinal tract of humans. 6,7 The ultimate goal 
of this project is to discover new antibiotics from soil samples 
collected from around the world. These new antibiotics will help 
prevent the spread of multidrug resistant strains of bacteria, and 
we will be able to combat new drug resistant bacteria. The world 
is in danger, and new antibiotics are all around waiting to be 
uncovered.
METHODS
Unless described otherwise, the bacterial strains and protocols used in 
this study were provided by the Tiny Earth Project Initiative (TEPI)
• We collected soil samples from a place with good vegetation, my 
sample was from 41.5041269, -90.5516124
• We then isolated a certain amount of bacteria in the soil sample by 
diluting the sample to 1:1000, 1:5000, and 1:10000, respectively, 
and grown on LB agar, 10% TSA, and PDA media.
• We used B. subtilis and E. coli as ESKAPE tester strains to test the 
soil isolates for antibiotic properties.
• We picked and patched the isolates, if a pick and patch showed 
antibiotic properties it was restreaked on a fresh LB agar plate.
• Colony PCR was conducted on each colony that showed antibiotic
properties, respectively.
• The PCR was ran on an agarose gel to further isolate the 16S rRNA
• Once PCR worked, the PCR samples were shipped to the 
University of Iowa to be screened, and sequenced. 
• Once sequenced, BLAST was used to cross analyzed the 16S rRNA 
from a national database to better understand what genus the soil 
isolate comes from.
DISCUSSION
The DNA sequencing data suggests that the soil isolates JT-15-LB-
B. subtilis and JT-17-LB- B. subtilis are from the same genus 
Pseudomonas. The BLAST data suggests this because there is a 
99.43% and a 99.57% match to another bacterial isolate’s 16S rRNA 
sequence. The future direction of the project will be to isolate the 
antibiotic within the bacteria by means of separation. Typically 
separated by size, polarity, solubility, or affinity.4 Finally, once 
complete separation and isolation is complete, NMR will be done to 
analyze the exact chemical structure of the possible antibiotic 
producer. If a new antibiotic is found, further assays will be 
conducted to determine if it is viable in vivo.
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RESULTS
Figure 2. Retesting possible antibiotic producers on LB agar plates confirms soil 
isolates 17, 15, and 12 show a distinct halo. All of the plates are LB agar media grown 
overnight at 28°C. Each possible antibiotic producing soil isolate was patched three 
times on each plate to further understand if the halo is a mistake, or if there is more 
than one type of bacteria in each patch. PDA was also repatched to see if the colonies 
would grow on LB and if there would be different results of antibiotic producing if 
grown on LB. All plates used Technique 2. Plate A is testing against E. coli. Plate B is 
testing against S. epidermidis which did not grow on LB particularly well. Plate C is 
testing against E. carotovora, which did not grow on LB particularly well. Plate D is 
testing against B. subtilis. The only plates to show signs of antibiotic producers were 
Plate A and D. As seen, there are distinct halos on Plate D for soil isolate 17, 15 and 
12. While on Plate A there is a little sign of a possible halo for soil isolate 15. Soil 
isolates 17 and 15 will be used for PCR and DNA purification to be sequenced.
Figure 3. Amplification of 16S ribosomal DNA was detected in the agarose gel, 
amplification occurred for soil isolates 15 and 17. Lane one is the 10Kb molecular 
weight standard. Lane 2 and 3 are soil isolate 17 from the LB master plate, and lanes 4 
and 5 are soil isolate 15 from the 10% TSA master plate. All of the bands are the 16S 
rDNA and are the correct size of Kb. These samples were used for DNA sequencing, 
will be cut out from the gel, and purified.
RESULTS (CONTINUED)
Figure 4. DNA sequencing BLAST data shows that the soil isolate 
JT-17-LB-B. subtilis, the first 4 entries, and JT-15-LB-B. subtilis, 
the last 3 entries as potential antibiotic producer is under the genus 
Pseudomonas. This makes sense because Pseudomonas is one of the 
most common bacteria found in soil. As seen in the Percent 
Identification column, there is a 99.57% match for 15 and a 99.43% 
match for 17 to another 16S rRNA sequence meaning it is very 
likely the soil isolate is of this genus. The E value is 0.0, meaning 
that there is no chance that this is random, if it was any number 
above 0 it would mean there is a possibility that the match is by 
chance. 8
